Venture Capital Panelist Presentation Slides - Chbmr.com

Recommendations

Info

VG Partners Life Sciences Team VG Partners Life Sciences Team Offers… Established, stable partnership Investment experience <strong>com</strong>patible with Canadian industry stage and sectors Best in class investment practices Strong North American network – VCs and Corporate Track record of leading and syndicating transactions Dominant VC in Canada with privileged access to deal flow Confidential and Proprietary 30
VG Partners Life Sciences Team Four Active Advisors Complement the Team Dr. Harold Wodlinger Cardiology & MedTech Biotech Entrepreneurial Success Dr. Teo Dagi Neurology & MedTech Advisor Value-add International Network & Deal Flow Team Value: <strong>Venture</strong> Network Operational Technical Deal Structuring Deep domain Expertise Dr. Charlie Bishop Metabolic Diseases Biotech/Pharma Backgrounds Dr. Elisabeth Corsi Oncology & Anti-Infectious Confidential and Proprietary 31
Page 1 and 2: Christine Sarkisian Trade Commissio
Page 3 and 4: The New England Economy • Thrives
Page 5 and 6: The Consulate’s Priority Sectors
Page 7 and 8: Virtual Trade Commissioner Powerful
Page 9 and 10: Opportunities • Agriculture, Food
Page 11 and 12: Opportunities • Ocean Technologie
Page 13 and 14: Life Sciences Connections • 500 b
Page 15 and 16: Our Team Consul General Pat Binns M
Page 17 and 18: Dr. Peter Farina Canaan Partners
Page 19 and 20: OVERVIEW About Canaan Partners » 2
Page 21 and 22: Areas of Interest » Biologics & Sm
Page 23 and 24: Typical Investment » Phase I or Ph
Page 25 and 26: Canaan Investment Model » Canaan u
Page 27 and 28: Dr. Luc Marengère VenGrowth Partne
Page 29: VG Partners Life Sciences Team Team
Page 33 and 34: Our track record - Capital Leverage
Page 35 and 36: VG Partners: Our Value-Add VisualSo
Page 37 and 38: Creating Sustainable Value Luc Mare
Page 39 and 40: Synergy Partners International Syne
Page 41 and 42: Synergy Interests Cancer Therapy an
Page 43 and 44: Representative Portfolio Companies
Page 45 and 46: TVM Capital Life Sciences Practice
Page 47 and 48: TVM Capital life science profile
Page 49 and 50: Creating substantial companies Sour
Page 51 and 52: Long-term stability paired with gro
Page 53 and 54: Projected Growth of Large Pharmaceu
Page 55 and 56: Two Emerging Strategies In Life Sci
Page 57 and 58: Tom Hayes GrowthWorks Atlantic Ltd
Page 59 and 60: GrowthWorks Overview � GrowthWork
Page 61 and 62: Retail venture capital (RVC) � Ra
Page 63 and 64: Contributions from Provincial Treas
Page 65 and 66: GWA Portfolio Companies Company Sec
Page 67 and 68: Dr. Christian Cortis Advanced Techn
Page 69 and 70: 69 ATV OVERVIEW � Now in its 30 t
Page 71 and 72: 71 Characteristics of Compelling In
Page 73 and 74: 73 Recent Life Science Investments
Page 75 and 76: Hercules Technology Growth Capital
Page 77 and 78: HTGC Life Science Underwriting Guid
Page 79 and 80: 79 Life Sciences Portfolio at a Gla

Venture Capital Panelist Presentation Slides - Chbmr.com

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?